Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity

References

• Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nature Reviews Cancer. 2012;12:298-306. doi:10.1038/nrc3245. PMID:22419253
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nature Medicine. 2015;21:938-45. doi:10.1038/nm.3909. PMID:26193342
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Communications. 2013;4:2612. doi:10.1038/ncomms3612. PMID:24113773
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202-9. doi:10.1038/nature13480. PMID:25079317
   PubMed Web of Science ®Google Scholar
• Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature Medicine. 2015;21:449-56. doi:10.1038/nm.3850. PMID:25894828
   PubMed Web of Science ®Google Scholar
• Lin SJ, Gagnon-Bartsch JA, Tan IB, Earle S, Ruff L, Pettinger K, Ylstra B, van Grieken N, Rha SY, Chung HC, et al. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut 2015;64:1721-31. doi:10.1136/gutjnl-2014-308252. PMID:25385008
   PubMed Web of Science ®Google Scholar
• Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63:236-43. doi:10.1136/gutjnl-2013-304531. PMID:23580779
   PubMed Web of Science ®Google Scholar
• Kim SY, Park C, Kim HJ, Park J, Hwang J, Kim JI, Choi MG, Kim S, Kim KM, Kang MS. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes. Gastroenterology. 2015;148:137-47 e9
   Google Scholar
• Derks S, Liao X, Chiaravalli AM, Xu X, Camargo MC, Solcia E, Sessa F, Fleitas T, Freeman GJ, Rodig SJ, et al. Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers. Oncotarget. 2016;7:32925-32. doi:10.18632/oncotarget.9076. PMID:27147580
   PubMed Web of Science ®Google Scholar
• Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, Jiang P, Shen H, Aster JC, Rodig S, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biology. 2016;17:174. doi:10.1186/s13059-016-1028-7. PMID:27549193
   PubMed Web of Science ®Google Scholar
• Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160:48-61. doi:10.1016/j.cell.2014.12.033. PMID:25594174
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330-7. doi:10.1038/nature11252. PMID:22810696
   PubMed Web of Science ®Google Scholar
• Chifman J, Pullikuth A, Chou JW, Bedognetti D, Miller LD. Conservation of immune gene signatures in solid tumors and prognostic implications. BMC Cancer. 2016;16:911. doi:10.1186/s12885-016-2948-z. PMID:27871313
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nature Immunology. 2013;14:1014-22. doi:10.1038/ni.2703. PMID:24048123
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Kroemer G. Targeting PD-1/PD-L1 interactions for cancer immunotherapy. Oncoimmunology. 2012;1:1223-5. doi:10.4161/onci.21335. PMID:23243584
   PubMed Web of Science ®Google Scholar
• Schalper KA, Carvajal-Hausdorf D, McLaughlin J, Altan M, Velcheti V, Gaule P, Sanmamed MF, Chen L, Herbst RS, Rimm DL. Differential expression and significance of PD-L1, IDO-1, and B7-H4 in human lung cancer. Clinical Cancer Research: an official journal of the American Association for Cancer Research. 2017;23:370-8. doi:10.1158/1078-0432.CCR-16-0150. PMID:27440266
   PubMed Web of Science ®Google Scholar
• Drake CG, Jaffee E, Pardoll DM. Mechanisms of immune evasion by tumors. Advances in Immunology. 2006;90:51-81. doi:10.1016/S0065-2776(06)90002-9. PMID:16730261
   PubMed Web of Science ®Google Scholar
• Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL, Kim WH. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. British Journal Of Cancer. 2008;99:1704-11. doi:10.1038/sj.bjc.6604738. PMID:18941457
   PubMed Web of Science ®Google Scholar
• Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H, Fujii H. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. British Journal Of Cancer. 2008;98:148-53. doi:10.1038/sj.bjc.6604149. PMID:18087278
   PubMed Web of Science ®Google Scholar
• Song HJ, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, Kim M, Kim S, Park CK, Kim S. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology. 2010;139:84-92.e2. doi:10.1053/j.gastro.2010.04.002. PMID:20398662
   PubMed Web of Science ®Google Scholar
• Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. The New England Journal Of Medicine. 2015;372:2018-28. doi:10.1056/NEJMoa1501824. PMID:25891174
   PubMed Web of Science ®Google Scholar
• Kulangara K, Hanks DA, Waldroup S, Peltz L, Shah S, Roach C, et al. Development of the combined positive score (CPS) for the evaluation of PD-L1 in solid tumors with the immunohistochemistry assay PD-L1 IHC 22C3 pharmDx. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2017;35:( suppl; abstr e14589). doi:10.1200/JCO.2017.35.15_suppl.e14589 (published online before print).
   Web of Science ®Google Scholar
• Roach C, Zhang N, Corigliano E, Jansson M, Toland G, Ponto G, Dolled-Filhart M, Emancipator K, Stanforth D, Kulangara K, et al. Development of a companion diagnostic PD-L1 immunohistochemistry assay for pembrolizumab therapy in non-small-cell lung cancer. Applied Immunohistochemistry & Molecular Morphology: AIMM. 2016;24:392-7. doi:10.1097/PAI.0000000000000408
   PubMedGoogle Scholar
• Poirel CL, Owens CC, 3rd, Murali TM. Network-based functional enrichment. BMC bioinformatics. 2011;12 Suppl 13:S14. doi:10.1186/1471-2105-12-S13-S14. PMID:22479706
   PubMed Web of Science ®Google Scholar
• Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Research 2011;39:D691-7. doi:10.1093/nar/gkq1018. PMID:21067998
   PubMed Web of Science ®Google Scholar
• Lee J, Lim DH, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2012;30:268-73. doi:10.1200/JCO.2011.39.1953. PMID:22184384
   PubMed Web of Science ®Google Scholar
• Choi HS, Ha SY, Kim HM, Ahn SM, Kang MS, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, et al. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients. Oncotarget 2016;7:7940-51. doi:10.18632/oncotarget.6958. PMID:26799288
   PubMed Web of Science ®Google Scholar
• Lee J, Sohn I, Do IG, Kim KM, Park SH, Park JO, Park YS, Lim HY, Sohn TS, Bae JM, et al. Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery. PloS One. 2014;9:e90133. doi:10.1371/journal.pone.0090133. PMID:24598828
   PubMed Web of Science ®Google Scholar
• Lin SJ, Gagnon-Bartsch JA, Tan IB, Earle S, Ruff L, Pettinger K, et al. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut 2015;64:1721-31. doi: 10.1136/gutjnl-2014-308252. PMID:25385008
   PubMed Web of Science ®Google Scholar
• Waggott D, Chu K, Yin S, Wouters BG, Liu FF, Boutros PC. NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics. 2012;28:1546-8. doi:10.1093/bioinformatics/bts188. PMID:22513995
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139-40. doi:10.1093/bioinformatics/btp616. PMID:19910308
   PubMed Web of Science ®Google Scholar
• Kang SY, Park CK, Chang DK, Kim JW, Son HJ, Cho YB, Yun SH, Kim HC, Kwon M, Kim KM. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. International Journal of Cancer. 2015;136:1568-78. doi:10.1002/ijc.29133. PMID:25110875
   PubMed Web of Science ®Google Scholar
• Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280 A in cancer patients. Nature. 2014;515:563-7. doi:10.1038/nature14011. PMID:25428504
   PubMed Web of Science ®Google Scholar
• Cho J, Lee J, Bang H, Kim ST, Park SH, An JY, Choi MG, Lee JH, Sohn TS, Bae JM, et al. Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability. Oncotarget. 2017;8(8):13320-13328. PMID:28076847
   PubMed Web of Science ®Google Scholar